Dividend Investor With $1.05 Million In Stocks And $36,600 Annual Payout Shares Portfolio – 'Could These Picks Set You Up for Life?' — Feb 15th, 2025

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. For many investors, the strategy is simple: invest once and enjoy the rewards for a lifetime. Dividend investing, particularly, has long been a popular approach for those who want a steady...

Hercules Capital Receives Affirmed BBB- Investment Grade Corporate and Unsecured Credit Rating from Fitch Ratings, Inc. — Jul 1st, 2025

SAN MATEO, Calif., July 01, 2025--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capita...

Hercules Capital (HTGC) Flat As Market Gains: What You Should Know — Apr 11th, 2025

Hercules Capital (HTGC) closed the latest trading day at $16.83, indicating no change from the previous session's end. This change lagged the S&P 500's daily gain of 1.81%. On the other hand, the Dow registered a gain of 1.56%, and the technology-centric Nasdaq increased by 2.06%. Coming ...

Hercules Capital prices upsized offering of $350M 6% notes due 2030 — Jun 11th, 2025

* Hercules Capital (NYSE:HTGC [https://seekingalpha.com/symbol/HTGC]) has priced an upsized underwritten public offering of $350M in aggregate principal amount of 6% notes due June 2030. * The closing of the transaction is subject to customary closing conditions and the notes are expec...

How to Boost Your Portfolio with Top Finance Stocks Set to Beat Earnings — Mar 24th, 2025

Two factors often determine stock prices in the long run: earnings and interest rates. Investors can't control the latter, but they can focus on a company's earnings results every quarter. The earnings figure itself is key, but a beat or miss on the bottom line can sometimes be just as, i...

Hercules Capital Inc (HTGC) Q1 2025 Earnings Call Highlights: Strong Portfolio Growth and ... — May 2nd, 2025

Net Debt Portfolio Growth: Nearly $270 million in Q1. Bond Offering: $287.5 million of 4.75% convertible unsecured notes due 2028. Assets Under Management: Over $5 billion, an 11% increase year-over-year. First Lien Exposure: Approximately 91%. Liquidity: Over $1 billion across the platfor...

Dyne Therapeutics Secures Up to $275 Million in Debt Financing from Hercules Capital — Jun 30th, 2025

Dyne Therapeutics, Inc. - $100 million funded upfront; additional $175 million tied to milestones provides strategic flexibility through key inflection points - WALTHAM, Mass., June 30, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on de...

Ares Capital Shares Decline 2.7% as Q1 Earnings Miss Estimates — Apr 30th, 2025

Shares of Ares Capital Corporation ARCC lost 2.7% in Tuesday’s trading session on lower-than-expected results. Its first-quarter 2025 core earnings of 50 cents per share missed the Zacks Consensus Estimate of 54 cents. The bottom line also reflected a decline of 15.3% from the prior-year...

Investing in Hercules Capital (NYSE:HTGC) five years ago would have delivered you a 187% gain — May 9th, 2025

While Hercules Capital, Inc. (NYSE:HTGC) shareholders are probably generally happy, the stock hasn't had particularly good run recently, with the share price falling 16% in the last quarter. But the silver lining is the stock is up over five years. In that time, it is up 70%, which isn't b...

Hercules Capital Closes Upsized Institutional Notes Offering of $350.0 Million 6.000% Unsecured Notes due 2030 — Jun 16th, 2025

Notes due 2030 Initially Assigned a Baa3 by Moody’s Investors Service and a BBB- by Fitch Ratings, Inc. SAN MATEO, Calif., June 16, 2025--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) ("Hercules" or the "Company"), today announced that it has closed an upsized underwritten public...

Hercules Capital (HTGC) Rises Higher Than Market: Key Facts — Apr 17th, 2025

Hercules Capital (HTGC) closed the latest trading day at $17.54, indicating a +1.8% change from the previous session's end. This change outpaced the S&P 500's 0.13% gain on the day. Elsewhere, the Dow saw a downswing of 1.33%, while the tech-heavy Nasdaq depreciated by 0.13%. The the stoc...

RBC Capital Maintains a Buy Rating on Dyne Therapeutics (DYN) With a $25 PT — Jul 11th, 2025

Dyne Therapeutics, Inc. (NASDAQ:DYN) is one of the 13 Best Healthcare Stocks to Buy Under $10. In a report released on July 7, Luca Issi from RBC Capital maintained a Buy rating on Dyne Therapeutics, Inc. (NASDAQ:DYN) with a price target of $25.00. A lab technician working with chemicals ...

Hercules Capital (HTGC) Gains As Market Dips: What You Should Know — Jul 11th, 2025

In the latest close session, Hercules Capital (HTGC) was up +1.07% at $18.94. The stock's performance was ahead of the S&P 500's daily loss of 0.33%. At the same time, the Dow lost 0.63%, and the tech-heavy Nasdaq lost 0.22%. Coming into today, shares of the specialty finance company had ...

Hercules Capital Announces Date for Release of First Quarter 2025 Financial Results and Conference Call — Apr 17th, 2025

SAN MATEO, Calif., April 17, 2025--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capit...

Dyne Therapeutics Secures Up to $275 Million in Debt Financing from Hercules Capital — Jun 30th, 2025

- $100 million funded upfront; additional $175 million tied to milestones provides strategic flexibility through key inflection points - WALTHAM, Mass., June 30, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional imp...

Savara's SWOT analysis: biotech firm's stock poised for growth with aPAP drug — Jun 14th, 2025

Savara Inc. (NASDAQ:SVRA), a biotechnology company specializing in rare respiratory diseases with a market capitalization of $466 million, is poised for a potential breakthrough with its lead candidate Molbreevi. According to InvestingPro data, the company’s stock has experienced signifi...

Hercules Capital (HTGC) Advances But Underperforms Market: Key Facts — Mar 24th, 2025

In the latest market close, Hercules Capital (HTGC) reached $19.32, with a +0.42% movement compared to the previous day. The stock trailed the S&P 500, which registered a daily gain of 1.77%. Elsewhere, the Dow gained 1.42%, while the tech-heavy Nasdaq added 2.28%. The specialty finance c...

Altimmune Secures Up to $100 Million in Credit Facility from Hercules Capital — May 13th, 2025

Altimmune, Inc Term loan adds balance sheet strength and provides financial flexibility to support continued development of pemvidutide GAITHERSBURG, Md., May 13, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel pept...

Hercules Capital Issues $350M in 6% Notes Due 2030 — Jun 16th, 2025

Hercules Capital, Inc. (NYSE:HTGC), a leader in customized debt financing for venture growth stage companies with a market capitalization of $3.09 billion, has entered into a Ninth Supplemental Indenture with U.S. Bank Trust Company, National Association, as trustee, on Monday. The agreeme...

Hercules Capital Inc (HTGC) Q1 2025 Earnings Call Highlights: Strong Portfolio Growth and ... — May 2nd, 2025

Net Debt Portfolio Growth: Nearly $270 million in Q1. Bond Offering: $287.5 million of 4.75% convertible unsecured notes due 2028. Assets Under Management: Over $5 billion, an 11% increase year-over-year. First Lien Exposure: Approximately 91%. Liquidity: Over $1 billion across the platfor...

Hercules Capital: Q1 Earnings Snapshot — May 1st, 2025

SAN MATEO, Calif. (AP) — SAN MATEO, Calif. (AP) — Hercules Capital, Inc. (HTGC) on Thursday reported first-quarter net income of $50.3 million. The San Mateo, California-based company said it had net income of 29 cents per share. Earnings, adjusted for investment costs, came to 45 cen...

Correction: Hercules Capital Receives Secured Debt Rating Upgrade to BBB from Fitch Ratings, Inc. — Apr 16th, 2025

SAN MATEO, Calif., April 16, 2025--(BUSINESS WIRE)--This press release corrects, replaces and entirely supersedes a prior version published on April 16, 2025. Hercules Capital, Inc. (NYSE: HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovati...

Hercules Capital Full Year 2024 Earnings: EPS Misses Expectations — Feb 15th, 2025

Hercules Capital (NYSE:HTGC) Full Year 2024 Results Key Financial Results Revenue: US$493.6m (up 7.1% from FY 2023). Net income: US$263.0m (down 21% from FY 2023). Profit margin: 53% (down from 73% in FY 2023). The decrease in margin was driven by higher expenses. EPS: US$1.63 (down from...

Hercules Capital Declares a Total Cash Distribution of $0.47 Per Share for the First Quarter 2025 — Apr 29th, 2025

The Total Cash Distribution of $0.47 per Share for the First Quarter 2025 is Comprised of a $0.40 per Share Base Distribution and an $0.07 per Share Supplemental Distribution SAN MATEO, Calif., April 29, 2025--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) ("Hercules" or the "Compan...

ARCC vs. HTGC: Which BDC Has More Upside Amid Market Uncertainty? — May 22nd, 2025

Ares Capital Corporation ARCC and Hercules Capital, Inc. HTGC are two leading Business Development Companies (BDCs) that provide debt financing to private companies. While ARCC focuses on middle-market firms across various industries, HTGC carves out a niche in venture debt, targeting high...

Hercules Capital prices upsized notes of $350M — Jun 12th, 2025

* Hercules Capital (NYSE:HTGC [https://seekingalpha.com/symbol/HTGC]) priced an upsized [https://seekingalpha.com/pr/20134244-hercules-capital-prices-upsized-institutional-notes-offering-of-350_0-million-6_000-percent] underwritten public offering of $350M in aggregate principal amount o...

Merck's Dealmaking Intensifies With MoonLake Bid As Keytruda Patent Cliff Nears: Report — Jun 3rd, 2025

US drug giant Merck & Co Inc (NYSE:MRK) reportedly approached Swiss biotech MoonLake Immunotherapeutics (NASDAQ:MLTX) with a bid exceeding $3 billion. While MoonLake turned down the initial offer, talks may be revived. The potential deal signals renewed dealmaking activity as investor pr...

3 Reliable Dividend Stocks With Yields Above 5% That You Can Buy With Less Than $100 Right Now — Oct 12th, 2024

There's no wrong way to put your money to work on Wall Street, but some methods produce more reliable gains than others. If you're looking for a relatively safe and easy way to grow the stream of income you'll have to work with during your retirement years, buying dividend-paying stocks an...

Wall Street Analysts Think Hercules Capital (HTGC) Is a Good Investment: Is It? — Jun 20th, 2025

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter? Let's take...

Hercules Capital (HTGC) Ascends While Market Falls: Some Facts to Note — Jun 18th, 2025

Hercules Capital (HTGC) closed at $18.02 in the latest trading session, marking a +1.24% move from the prior day. This move outpaced the S&P 500's daily loss of 0.03%. Elsewhere, the Dow lost 0.11%, while the tech-heavy Nasdaq added 0.13%. Shares of the specialty finance company have depr...

3 Reliable Dividend Stocks With Yields Above 5% That You Can Buy With Less Than $100 Right Now — Oct 12th, 2024

There's no wrong way to put your money to work on Wall Street, but some methods produce more reliable gains than others. If you're looking for a relatively safe and easy way to grow the stream of income you'll have to work with during your retirement years, buying dividend-paying stocks an...

Hercules Capital (HTGC) Q1 Earnings and Revenues Lag Estimates — May 1st, 2025

Hercules Capital (HTGC) came out with quarterly earnings of $0.45 per share, missing the Zacks Consensus Estimate of $0.46 per share. This compares to earnings of $0.50 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings s...

MoonLake Immunotherapeutics Reports First Quarter 2025 Financial Results and Provides a Business Update — May 12th, 2025

MoonLake Immunotherapeutics AG MoonLake Immunotherapeutics Reports First Quarter 2025 Financial Results and Provides a Business Update Continued to make significant progress with the development of the Nanobody® sonelokimab across portfolio of indications, including Phase 3 studies in h...

Hercules Capital (HTGC) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates — May 1st, 2025

Hercules Capital (HTGC) reported $119.51 million in revenue for the quarter ended March 2025, representing a year-over-year decline of 1.7%. EPS of $0.45 for the same period compares to $0.50 a year ago. The reported revenue represents a surprise of -1.91% over the Zacks Consensus Estimat...

Hercules Capital (HTGC) Outperforms Broader Market: What You Need to Know — Jul 2nd, 2025

Hercules Capital (HTGC) closed at $18.59 in the latest trading session, marking a +1.36% move from the prior day. The stock outpaced the S&P 500's daily gain of 0.48%. At the same time, the Dow lost 0.02%, and the tech-heavy Nasdaq gained 0.94%. Shares of the specialty finance company wit...

Q1 2025 Hercules Capital Inc Earnings Call — May 2nd, 2025

Participants Michael Hara; Investor Relations; Hercules Capital Inc Scott Bluestein; President, Chief Executive Officer, Chief Investment Officer, Director; Hercules Capital Inc Seth Meyer; Chief Financial Officer; Hercules Capital Inc Brian McKenna; Analyst; Citizens Crispin Love; An...

Hercules Capital Announces Date of 2025 Annual Meeting of Stockholders — May 8th, 2025

SAN MATEO, Calif., May 08, 2025--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) ("Hercules" or the "Company"), will conduct its 2025 Annual Meeting of Stockholders by virtual meeting on Wednesday, June 18, 2025 at 9:00 a.m. (Eastern Time). The proxy statement for the meeting was file...

HTGC's Q1 Earnings Lag Estimates, Total Investment Income Dips — May 2nd, 2025

Hercules Capital Inc.’s HTGC first-quarter 2025 net investment income of 45 cents per share missed the Zacks Consensus Estimate by a penny. The bottom line declined 10% from the year-ago quarter. Results were adversely affected by weak performance in the interest, dividend and fee i...

50-Year-Old Investor Craves 8%+ Yield, Snubs Ford, Chases Durable Dividends – 'I Am Willing To Consider Anything' For Monthly Income — Apr 21st, 2025

In today's unpredictable market, investors seeking high yields need to balance risk and reward carefully. With rising volatility, inflation concerns, and fluctuating interest rates, a well-diversified portfolio is crucial to sustaining durable income. For income-focused investors, especia...

Hercules Capital Reports First Quarter 2025 Financial Results — May 1st, 2025

Q1 2025 Total Gross Debt and Equity Commitments of $1.02 Billion Q1 2025 Total Gross Fundings of $539.1 Million Q1 2025 Total Investment Income of $119.5 Million Q1 2025 Net Investment Income "NII" of $77.5 Million, or $0.45 per Share Q1 2025 NII of $0.45 per Share, provides 113% Cover...

Ares Capital Misses on Q1 Earnings: Should You Sell or Hold the Stock? — May 8th, 2025

Ares Capital Corporation ARCC announced its first-quarter 2025 results on April 29, recording lower portfolio exits and gross commitments. The company’s top and bottom-line numbers lagged the Zacks Consensus Estimate. This was mainly due to net realized and unrealized losses of $124 mill...

Exploring Analyst Estimates for Hercules Capital (HTGC) Q1 Earnings, Beyond Revenue and EPS — Apr 28th, 2025

Wall Street analysts forecast that Hercules Capital (HTGC) will report quarterly earnings of $0.46 per share in its upcoming release, pointing to a year-over-year decline of 8%. It is anticipated that revenues will amount to $121.83 million, exhibiting an increase of 0.2% compared to the y...

Hercules Capital Renews and Increases Its Credit Facility with MUFG Bank, Ltd. to $440.0 Million — Jun 12th, 2025

SAN MATEO, Calif., June 12, 2025--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) ("Hercules" or the "Company"), the largest and leading specialty finance provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital ...

Hercules Capital Receives Investment Grade Rating Upgrade to BBB from Fitch Ratings, Inc. — Apr 16th, 2025

SAN MATEO, Calif., April 16, 2025--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capit...